|
시장보고서
상품코드
2058297
반려동물용 암 치료제 시장 : 치료법별, 반려동물 종류별, 투여 경로별, 용도별, 지역별Pet Cancer Therapeutics Market, By Therapy Type, By Pet Type, By Mode of Administration, By Application, By Geography |
||||||
반려동물용 암 치료제 시장은 2026년에 117억 달러로 추정되며, 2033년까지 187억 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 8.3%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 117억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.30% | 2033년 시장 규모 예측: | 187억 달러 |
반려동물용 항암제에는 화학요법제, 표적 치료제, 병용요법 및 면역요법 백신이 포함되며, 이들은 수의사에 의해 일반적으로 권장되고 있습니다. 이러한 약물은 주로 림프종, 비만세포종, 섬유육종, 혈관육종 등 다양한 질환의 치료에 권장됩니다. 현재 세계 시장에서는 반려동물 암 치료를 위해 다양한 제형이 이용 가능하며, 정제, 주사제 또는 외용제로 투여할 수 있습니다. 이처럼 치료법 선택의 폭이 넓기 때문에 반려동물은 병세를 억제하는 데 적합한 효과적인 암 치료를 받기 쉬워졌습니다.
시장 역학
반려동물용 항암제 시장의 성장을 이끄는 주요 요인으로는 림프종이나 흑색종과 같이 유병률이 높은 질환의 치료를 목표로 하는 다수의 파이프라인 약물이 있다는 점을 꼽을 수 있습니다. 예를 들어, 2017년에는 아라타나 테라퓨틱스(Aratana Therapeutics)가 미국 농무부(USDA) 수의생물제제센터로부터 1세 이상의 골육종 진단을 받은 개를 대상으로 한 개용 골육종 백신 'AT-014'의 승인을 획득했습니다. 이 후보 약물은 아드바시스(Advaxis)사로부터 독점적으로 라이선스를 취득한 것으로, 현재 3상 임상시험이 진행 중입니다. 또한, 수의 종양학회(Veterinary Cancer Society), 펫코 재단(Petco Foundation), 동물암 재단(Animal Cancer Foundation) 등 민간 및 정부 기관이 협력하여 개와 고양이를 위한 신약 개발에 힘쓰고 있으며, 이는 예측 기간 동안 반려동물용 항암제 시장의 성장을 견인하는 주요 요인이 될 것으로 전망됩니다. 그러나 반려동물 질병에 대한 인식 부족, 높은 비용, 그리고 약물의 부작용이 반려동물용 항암제 시장의 성장을 저해하는 요인으로 작용하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 반려동물용 항암제 시장의 주요 기업 개요을 작성하였습니다 : 기업 개요, 재무 실적, 제품 포트폴리오, 시장 입지, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 반려동물용 항암제 시장 분석에 활용된 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 반려동물용 암 치료제 시장 : 요법 유형별, 2021-2033년
제5장 세계의 반려동물용 암 치료제 시장 : 펫 유형별, 2021-2033년
제6장 세계의 반려동물용 암 치료제 시장 : 투여 방법별, 2021-2033년
제7장 세계의 반려동물용 암 치료제 시장 : 용도별, 2021-2033년
제8장 세계의 반려동물용 암 치료제 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSM 26.06.19Pet Cancer Therapeutics Market is estimated to be valued at USD 11.7 Bn in 2026 and is expected to reach USD 18.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 18.7 Bn |
The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.
Market Dynamics
The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2017, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global pet cancer therapeutics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market
Market Segmentation
- By Therapy Type: (Revenue, USD Bn, 2021-2033)
- Chemotherapy
- Targeted Therapy
- Combination Therapy
- Immunotherapy
- By Pet Type: (Revenue, USD Bn, 2021-2033)
- Cat
- Dog
- Horse
- By Mode of Administration: (Revenue, USD Bn, 2021-2033)
- Oral
- Intravenous
- Topical
- By Application: (Revenue, USD Bn, 2021-2033)
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Others
- By Region: (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Aratana Therapeutics, Inc.
- AB Science
- Boehinger Ingelheim International GmbH
- Zenoaq
- Morphogenesis, Inc.
- VetDC, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- Rhizen Pharmaceuticals SA
- Oasmia Pharmaceuticals AB
- Zoetis
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Pet Type
- Market Snippet, By Mode of Administration
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Pipeline Analysis
- Regulatory Guidelines
- Initiatives for Prevention of Pet Cancer
- Approved Targeted Therapies for Pet Cancer
- Epidemiology
4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Pet Cancer Therapeutics Market, By Pet Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Cat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dog
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Horse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Pet Cancer Therapeutics Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mast Cell Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mammary and Squamous Cell Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Pet Cancer Therapeutics Market, By Region, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Aratana Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- AB Science
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Boehringer Ingelheim International GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Zenoaq
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Morphogenesis, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- VetDC, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Karyopharm Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Rhizen Pharmaceuticals SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Regeneus Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Oasmia Pharmaceuticals AB
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Zoetis
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- Aratana Therapeutics, Inc.
10. Section
- References
- Research Methodology
- About us and Sales Contact
